Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Amyloidosis and Amyloidogenesis: One Name, Many DiseasesPathophysiology of Cardiac Amyloidosis
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis
Clinical Use of Biomarkers in Cardiac Amyloidosis
Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update
Standard Therapy in Cardiac Amyloidosis: What is Known, What is “Gray”
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis

